Curaleaf Holdings (CURLF) Cost of Revenue (2019 - 2026)

Curaleaf Holdings (CURLF) recorded quarterly Cost of Revenue of $166.9 million in Q1 2026, up 97370.7% quarter-over-quarter from $171273.0 in Q4 2025, and up 10.51% on a YoY basis from $151.1 million in Q1 2025.

Curaleaf Holdings (CURLF) Cost of Revenue (2019 - 2026) Analysis & Trends

Curaleaf Holdings' Cost of Revenue history runs 8 years deep, the most recent figure standing at $166.9 million for Q1 2026.

  • In Q1 2026, Cost of Revenue rose 10.51% year-over-year to $166.9 million; the TTM figure through Mar 2026 stood at $327.8 million (down 50.82% YoY), while the FY2025 annual figure was $637.1 million, down 8.13% from the prior year.
  • Cost of Revenue was $166.9 million for Q1 2026 at Curaleaf Holdings, up from $171273.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $274.4 million in Q4 2022 to a low of $161967.0 in Q2 2025.
  • Historically, Cost of Revenue has averaged $142.6 million across 5 years, with a median of $162.1 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Cost of Revenue slumped 99.93% in 2023, then soared 86456.8% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $274.4 million in 2022, then plunged by 99.93% to $189077.0 in 2023, then jumped by 86456.8% to $163.7 million in 2024, then slumped by 99.9% to $171273.0 in 2025, then surged by 97370.7% to $166.9 million in 2026.
  • The last three Cost of Revenue figures came in at $166.9 million (Q1 2026), $171273.0 (Q4 2025), and $160.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 696.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 641.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 133.40 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 34.44 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 13.80 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 586.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 155.56 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 52.68 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 222.00 Mn
10 Curaleaf Holdings - - 157.29 Mn 166.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 166.94 Mn
Mar 31, 2026 166.94 Mn
Dec 31, 2025 171,273.00
Dec 31, 2025 171,273.00
Sep 30, 2025 160.50 Mn
Sep 30, 2025 160.50 Mn
Jun 30, 2025 161,967.00
Jun 30, 2025 161,967.00
Mar 31, 2025 151.06 Mn
Mar 31, 2025 151.06 Mn
Dec 31, 2024 163.66 Mn
Dec 31, 2024 163.66 Mn
Sep 30, 2024 170.01 Mn
Sep 30, 2024 170.01 Mn
Jun 30, 2024 181.82 Mn
Jun 30, 2024 181.82 Mn
Mar 31, 2024 178.03 Mn
Mar 31, 2024 178.03 Mn
Dec 31, 2023 189,077.00
Dec 31, 2023 189,077.00